(Q43555468)

24 November 2017

title

High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis (English)

1 reference

24 November 2017

0 references

0 references

1 reference

Thomas Lahiri

1

1 reference

24 November 2017

Alyson Guillet

series ordinal

2

1 reference

24 November 2017

Sandra Diehl

series ordinal

3

1 reference

24 November 2017

Michael Ferguson

series ordinal

4

1 reference

24 November 2017

publication date

26 March 2013

1 reference

24 November 2017

published in

Pediatric Pulmonology

1 reference

24 November 2017

volume

49

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

148-153

1 reference

Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Acute renal failure after treatment with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Acute renal failure outcomes in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

3-5 year longitudinal follow-up of pediatric patients after acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Established and emerging markers of kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Serum tobramycin levels following delivery of tobramycin (Tobi) via eFlow advanced nebuliser in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Microalbuminuria as a screening tool in cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22795

21 January 2018

Identifiers

DOI

10.1002/PPUL.22795

1 reference

release_ccd4mtdhyzgcrd3a65meihyqyq

24 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ccd4mtdhyzgcrd3a65meihyqyq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference